Evidence map›Paper›PMID 34713805›Full record

ArticleeLife2021

Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.

Evgeniya Trofimenko, Gianvito Grasso, Mathieu Heulot, Nadja Chevalier, Marco A Deriu, Gilles Dubuis, Yoan Arribat, Marc Serulla, Sebastien Michel, Gil Vantomme and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. KCNN4 as a genomic determinant of cytosolic delivery by the attenuated cationic lytic peptide L17E.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Optimization of CRISPR-Cas system for clinical cancer therapy.Bioengineering & translational medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Evgeniya TrofimenkoDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-4910-5324
Gianvito Grasso *Dalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, Lugano, Switzerland.ORCID 0000-0002-7761-222X
Mathieu Heulot *Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-9641-941X
Nadja Chevalier *Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Marco A DeriuPolitoBIOMed Lab Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Torino, Italy.ORCID 0000-0003-1918-1772
Gilles DubuisDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Yoan ArribatDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-0952-5279
Marc SerullaDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-4166-1556
Sebastien MichelDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Gil VantommeDepartment of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-7441-0737
Florine OryDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Linh Chi DamDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-6874-2049
Julien PuyalDepartment of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-8140-7026
Francesca AmatiDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-1731-0262
Anita LüthiDepartment of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-4954-4143
Andrea DananiDalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, Lugano, Switzerland.ORCID 0000-0001-6578-5089
Christian WidmannDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-6881-0363
University of Lausanne · CHUniversity of Applied Sciences and Arts of Southern Switzerland · CHPolitecnico di Torino · ITUniversity Centre of Legal Medicine · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-penetrating peptides (CPPs) allow intracellular delivery of bioactive cargo molecules. The mechanisms allowing CPPs to enter cells are ill-defined. Using a CRISPR/Cas9-based screening, we discovered that KCNQ5, KCNN4, and KCNK5 potassium channels positively modulate cationic CPP direct translocation into cells by decreasing the transmembrane potential (V

Indexed as

AnimalsCell LineCell-Penetrating PeptidesHeLa CellsHumansMembrane PotentialsMiceMice, Inbred C57BLPotassium ChannelsProtein TransportRatsRats, Sprague-DawleyZebrafishCell-Penetrating PeptidesPotassium Channelscell biologycell-penetrating peptidesIn silico modelingmembrane potentialmousepotassium channelsTATwater poreszebrafish

Identifiers

PMID34713805
PMCPMC8639150
OpenAlexW3208528933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.